Glomerulonephritis, IGA: all 263 studies
Page 3 of 3. Open to participants first (102), then studies with results posted, then the rest; newest registration first within each.
- Tonsillectomy and Primitive IgA Nephropathy in Children: Strasbourg Cohort and Assessment Practices in Inter North East RegionStatus unknownNCT02829164
- Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA NephropathyStatus unknownNCT02765594Phase 4
- Integrative Medicine of IgA NephropathyStatus unknownNCT02712697Not applicable
- Validity and Security of Reh-acteoside Therapy for Patients of IgA NephropathyStatus unknownNCT02662283Phase 2/3
- Trial of Plasma Exchange for Severe Crescentic IgA NephropathyTerminatedNCT02647255Phase 2/3
- Efficacy and Safety of SM101 in the Treatment of IgA NephropathyWithdrawnNCT02605525Phase 2
- Rituximab in Recurrent IgA NephropathyStatus unknownNCT02571842Phase 4
- Biomarkers for the Progression of IgA NephropathyCompletedNCT02529722
- Autonomic Nervous System (ANS) and Renal Function in Immunoglobin A (IgA) NephropathyCompletedNCT02527902Not applicable
- Multicenter Study Evaluating the Performance of the Assay of Anti-hinge Region Antibodies in the Diagnosis of Progressive Forms of IgA NephropathyCompletedNCT02526966Not applicable
- Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive TreatmentTerminatedNCT02523768Phase 4
- The Correlation of Periostin and Renal Pathology in Chronic Kidney Disease PatientsCompletedNCT02493101
- Effect of Tonsillectomy on Longterm Renal Outcome of IgA NephropathySuspendedNCT02471599Not applicable
- Open Label Study of Fostamatinib in the Treatment of IgA NephropathyWithdrawnNCT02433236Phase 2
- Acthar on Proteinuria in IgA Nephropathy PatientsWithdrawnNCT02382523Phase 4
- Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy: a Self- Controlled StudyCompletedNCT02351752Phase 4
- Efficacy and Safety of Losartan in Children With Ig A NephropathyCompletedNCT02232776Phase 3
- Efficacy and Safety of Abelmoschus Manihot for IgA NephropathyStatus unknownNCT02231125Phase 4
- Treatment of IgAN With Multi-glycoside of Tripterygium Wilfordii HOOK. f.Status unknownNCT02187900Phase 3
- A Controlled Study of Steroids Therapy for Patients of IgA Nephropathy With Active Pathological Changes.Status unknownNCT02160132Phase 2
- BRIGHT-SC: Blisibimod Response in IgA Nephropathy Following At-Home Treatment by Subcutaneous AdministrationCompletedNCT02062684Phase 2/3
- BRILLIANT-SC: A Study of the Efficacy and Safety of Blisibimod Administration in Subjects With IgA NephropathyWithdrawnNCT02052219Phase 3
- Study of Standardized Treatment of Integrative Medicine With the Severe IgA NephropathStatus unknownNCT01879514Not applicable
- The Effects of Mycophenolate Mofetil (MMF) on Renal Outcomes in Advanced Immunoglobulin A (IgA) Nephropathy PatientsCompletedNCT01854814Not applicable
- Development of a Metabolic Assessment Tool for Chronic Kidney DiseaseCompletedNCT01838239Not applicable
- Probiotics in IgA NephropathyStatus unknownNCT01781312Not applicable
- IgA Nephropathy, Lymphocyte Homing and IgA Class SwitchCompletedNCT01775527Not applicable
- The Effects of Weight Reduction in IgA NephropathyStatus unknownNCT01773382Not applicable
- Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA NephropathyStatus unknownNCT01758120Phase 4
- The Effect of Nefecon® in Patients With Primary IgA Nephropathy at Risk of Developing End-stage Renal DiseaseCompletedNCT01738035Phase 2
- Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study (TESTING Low Dose Study)CompletedNCT01560052Not applicable
- A Survey of Factors Affecting an Early or Delayed Diagnosis of IgA NephropathyCompletedNCT01538433
- An Observational Study of IgA Nephropathy: Pathological Variants and Clinical DataCompletedNCT01502579
- The Effectiveness of Enough Steroids as Inducement Therapy in Minimal Change Disease-like IgA NephropathyCompletedNCT01451710Not applicable
- Steroids and Azathioprine in Advanced IgANCompletedNCT01392833Phase 3
- An Multi-site Prospective Study to Assess the Efficacy and Safety of MMF in the Treatment of Proliferative IgA Nephropathy(IgAN)CompletedNCT01269021Not applicable
- Additive Renoprotective Effects of Oral Calcitriol in IgA Nephropathy Patients Taking Renin-Angiotensin System BlockersCompletedNCT01237028Not applicable
- Treatment of Early Immunoglobulin A Nephropathy by Angiotensin Converting Enzyme Inhibitor - A Randomized Controlled TrialCompletedNCT01225445Phase 3
- A Study to Evaluate the Efficacy and Safety of Tacrolimus in Korean Nephropathy PatientsCompletedNCT01224028Phase 2
- Diet Intervention in Food Sensitive Patients With IgA NephropathyStatus unknownNCT01203007Not applicable
- A Prospective Study of the Kidney Protective Effect of Aliskiren in Hypertensive Patients With IgA NephropathyStatus unknownNCT01184599Phase 4
- Inhibitors of Angiotensin II in Proteinuric Mesangioproliferative GlomerulonephritisCompletedNCT01115426Phase 4
- Aliskiren for Proteinuric IgAN Despite Angiotensin BlockadeCompletedNCT00922311Phase 4
- Prospective Study of TW in Treatment of IgAN With Asymptomatic Abnormal UrinalysisTerminatedNCT00885547Not applicable
- Aliskiren for Immunoglobulin A (IgA) NephropathyCompletedNCT00870493Phase 3
- Mycophenolate Mofetil for IgA NephropathyCompletedNCT00863252Phase 4
- Safety Study of of Intravenous CCL2-LPM in Patients With IgA NephropathyTerminatedNCT00856674Phase 1
- Oral Treatment With PL-56 in Patients With IgA Nephropathy - an Explorative StudyCompletedNCT00767221Phase 2
- "Steroids and Azathioprine Versus Steroids Alone in IgAN"CompletedNCT00755859Phase 4
- Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN)CompletedNCT00657059Phase 3
- Paricalcitol for the Treatment of Immunoglobulin A NephropathyWithdrawnNCT00599963Phase 3
- Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA NephropathyCompletedNCT00554502Phase 3
- Efficacy and Safety of Omega-3 Fatty Acids(Omacor®) for the Treatment of Immunoglobulin A NephropathyCompletedNCT00549692Phase 3
- Role of Regulatory T Cells in Pathogenesis of Primary IgA NephropathyCompletedNCT00521508Not applicable
- A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA NephropathyCompletedNCT00426348Phase 4
- Sirolimus Therapy for Poor Prognosis Immunoglobulin A NephropathyCompletedNCT00396721Phase 2
- ACEi/ARB Alone Versus ACEi/ARB Plus Steroids in the Treatment of Primary IgA Nephropathy, a RCTStatus unknownNCT00378443Not applicable
- Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA NephropathyCompletedNCT00367562Phase 4
- Calcitriol in the Treatment of Immunoglobulin A (IgA) NephropathyCompletedNCT00319761Phase 4
- Mycophenolate Mofetil Versus Intravenous Cyclophosphamide Pulses in the Treatment of Crescentic IgA NephropathyCompletedNCT00301600Not applicable
- Pilot Study of Enalapril and Renal Function in Patients With IgA NephropathyCompletedNCT00006137Not applicable
- Alternate Day Prednisone or Daily Fish Oil Supplements in Patients With Immunoglobulin A NephropathyCompletedNCT00004448Phase 2
- Study of Genetic Anomalies of Complement Related Proteins in Patients With IgA GlomerulonephritisCompletedNCT00004305